VNDA ข่าวฟอเร็กซ์
Vanda Pharmaceuticals Receives Unsolicited, Non-binding $8.00/share Cash Offer From Cycle Group
Biopharmaceutical company Vanda Pharmaceuticals Inc. (VNDA) confirmed Thursday that it has received an unsolicited, non-binding indication of interest from Cycle Group Holdings Ltd. to acquire the Company for $8.00 per share in cash.
RTTNews
|
154 วันที่ผ่านมา
Vanda Pharma Says Phase II Study Of VQW-765 To Treat Anxiety Showed Lower Stress Levels
Vanda Pharmaceuticals Inc. (VNDA) reported on Friday results in a Phase II clinical study of VQW-765, a novel small molecule alpha 7 nicotinic acetylcholine receptor (a7-nAChR) partial agonist, in the treatment of acute performance anxiety in social situations, such as public speaking.
RTTNews
|
706 วันที่ผ่านมา
